Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Much Is the Global Controlled Substance Market Valued at Present and by 2029?
The scale of the controlled substance market has significantly expanded in the past few years. The market, which is projected to grow from $94.86 billion in 2024 to $100.19 billion in 2025, will experience a compound annual growth rate (CAGR) of 5.6%. The surge in growth during the historical period can be linked to advancements in medicine, establishing regulatory policies, the increasing prevalence of chronic illnesses, the growth of the pharmaceutical sector, international commerce, and collaboration efforts.
The market size for controlled substances is projected to experience substantial expansion in the coming years. The market will reach “$133.97 billion in 2029, with a compound annual growth rate (CAGR) of 7.5%. The projected growth in the upcoming period is influenced by factors like precision medicine, telemedicine and remote healthcare, alternatives to opioids, ongoing regulatory updates, and an amplified focus on mental health. Key trends predicted for this period are alterations in regulations and adherence to them, heightened attention towards drug safety and prevention of abuse, advancements in technologies for drug delivery, the rise of biosimilars and generic versions, and the incorporation of digital health solutions.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9898&type=smp
#What Drivers Are Influencing Growth In The Controlled Substance Market?
The growth of the controlled substance market is expected to be fueled by the rising demand for medically prescribed drugs. These prescription drugs, intended for treating, curing, mitigating, therapeutically intervening, or preventing sickness, commonly form part of controlled substances. They play a critical role in the controlled substance market by improving patient outcomes and reducing unnecessary expenditure. For example, a report released by the Centers for Medicare and Medicaid Services (CMS), a US federal agency, in September 2024 stated that spending on prescription drugs saw an uptick of 8.4% amounting to $405.9 billion in 2022, compared to a growth of 6.8% in 2021. As such, the surging demand for these medically prescribed drugs is steering the growth of the controlled substance market.
What Are The Main Segments Identified In The Controlled Substance Market Research?
The controlled substance market covered in this report is segmented –
1) By Drug: Opioids, Stimulant, Depressants, Cannabinoids
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By Application: Pain Management, Sleep Disorders, Depression And Anxiety, Seizure, Attention Deficit Hyperactivity Disorder (ADHD), Other Applications
Subsegments:
1) By Opioids: Natural Opioids, Semi-Synthetic Opioids, Synthetic Opioids
2) By Stimulants: Amphetamines, Methylphenidate, Cocaine
3) By Depressants: Benzodiazepines, Barbiturates, Sleep Medications
4) By Cannabinoids: THC (Tetrahydrocannabinol), CBD (Cannabidiol), Synthetic Cannabinoids
Which Trends Are Redefining The Future Landscape Of The Controlled Substance Industry?
A prevalent trend in the controlled substance market is product innovation. Leading corporations in this field are continuously creating new products and medications to hold their market position. For example, in January 2022, CareFlow Medicines Management Ltd. (CMM), a UK-based company specializing in medicine management solutions, teamed up with Modeus, a healthcare software provider from Australia, to introduce their Controlled Drug Manager (CD Manager). This inventive platform is geared towards efficient management and monitoring of controlled drugs, including those owned by patients. The new CMM CD Manager, backed by Modeus, is designed to interface with CMM’s medication management platform and additional external systems. It is designed for use by clinical staff and pharmacists in various hospital areas, like pharmacy, wards and theatres where controlled medications are stored. It features integrated reporting that aids Controlled Drug Accountable Officers in monitoring the controlled drugs’ lifecycle within an organization and responding rapidly to automatic alerts about inconsistencies or potential diversion.
Which Companies Play A Key Role In The Development Of The Controlled Substance Market?
Major companies operating in the controlled substance market include Merck & Co. Inc., Johnson and Johnson Services Inc., Orbis Biosciences Inc., GW Pharmaceuticals plc, Corium Inc., Aradigm Corporation, Alkermes plc, Sun Pharmaceutical Ltd., F. Hoffmann-La Roche Ltd., AbbVie Inc., Ampac Fine Chemicals, Siegfried Holding AG, Pfizer Inc., Novartis AG, GlaxoSmithKline plc, Sanofi S.A., Bristol-Myers Squibb, Eli Lilly and Company, AstraZeneca, Teva Pharmaceutical Industries, Viatris Inc., Boehringer Ingelheim, Gilead Sciences, Amgen, Regeneron Pharmaceuticals, Abbott Laboratories, Mallinckrodt Pharmaceuticals, Endo International, Catalent, Cambrex Corporation, Lonza Group, Indivior plc, Ipsen SA
Get The Full Report Here:
https://www.thebusinessresearchcompany.com/report/controlled-substance-global-market-report
What Are The Key Regional Developments Shaping The Controlled Substance Market?
North America was the largest region in the controlled substance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the controlled substance market report during the forecast period. The regions covered in the controlled substance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=9898&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model